ST. LOUIS, Sept. 13 /PRNewswire-FirstCall/ -- Monsanto Company (NYSE: MON) said today that it is responding to a civil investigative demand from the Iowa Attorney General's office and will provide information regarding its seed, trait, and chemistry related licensing and marketing programs to that office and any other interested state Attorneys General.

"Farmers buy seed each year based on the yield and value brought to their farms at harvest which has resulted in rapid and broad adoption of biotech seed products," said Monsanto's General Counsel David Snively. "Given the pace and scale of ag biotechnology adoption, it is understandable why regulators want to know more about competition in modern agriculture and how products are developed and used."

Monsanto's commercial business approach is to invest in seed and trait technology development to create products that increase yield and improve farm productivity. Monsanto broadly licenses improved germplasm and traits to hundreds of competing seed companies so that farmers who wish to plant seed with the company's technology and germplasm innovations can choose the seed brands they prefer.

Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. For more information about Monsanto, see: http://www.monsanto.com/.

SOURCE: Monsanto Company

CONTACT: Media, Tami Craig Schilling, +1-314-694-2247, or Analysts,
Scarlett Foster, +1-314-694-8148, both for Monsanto Company

Web site: http://www.monsanto.com/

Company News On-Call: http://www.prnewswire.com/comp/114341.html